LY9 and systemic lupus erythematosus: The analysis of CD8+ T cells and subsets identified that EM CD8+ T cell co-expressing SLAMF1, SLAMF3, SLAMF6 and SLAMF7, were significantly decreased in SLE patients (Figure 4B).